AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2025
Mar 15, 2025
35221_dirs_2025-03-14_4f468041-3429-4fd3-93f1-676f09f63f06.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2025-02-21
Reporting Person: Tasso Partners, LLC (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2574350 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Prefunded Warrant | $0.001 | 2030-02-18 | Common Stock (53974) | Direct |
Footnotes
F1: The prefunded warrant certificate provides that warrant becomes exercisable upon the date that the issuer's stockholders approve, for the purposes of the rules of The Nasdaq Stock Market LLC, the issuance of shares of common stock upon exercise of the prefunded warrant.
More from PAVmed Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Jan 23